News

J&J reported second quarter earnings Tuesday. The company is under scrutiny by investors as it faces drug patent cliffs.
The aftermath of the 12-day war with Iran looks mixed more than two weeks later. Iran’s nuclear program was badly damaged and likely set back for years.
UnitedHealth kicked off the year with a stark warning. In early January, management told investors to brace for rising ...
The cost-of-living adjustment for Social Security benefits is expected to be 2.7% in 2026, analysts said on Tuesday — but ...
The GOP's new budget bill includes steep cuts to Medicaid, which will have far-reaching effects on American health care and ...
Explore last week's key healthcare market trends, top gainers & losers, major deals, Trump's tariff plans, FDA approvals, and significant legal updates.
SelectQuote’s undervaluation, rising recurring revenue, and margin gains position it well for FY25 despite recent volatility.
The nonpartisan Congressional Budget Office projects that 2.9 million people who stand to lose Medicaid from President Donald Trump’s tax and spending law are already covered by Medicare or by ...
UnitedHealth Group is again responding to a Wall Street Journal story about billing practices for its Medicare Advantage plan ...
Companies such as UnitedHealth, Centene and Humana are getting squeezed between rising costs and a stingier government.
Justice Department prosecutors recently interviewed former employees about company practices that boost federal payments.